Morphological and immunophenotypic analysis of basal-like carcinoma of the breast

Bioscience Horizons

Volumn 1, Issue 1, 2008, Pages 19-27

  Winter, Joy ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

Basal like; Breast; Immunophenotype

Indexed keywords

EID: 84870954415     PISSN: None     EISSN: 17547431     Source Type: Journal    
DOI: 10.1093/biohorizons/hzn007     Document Type: Article

References (23)

1. Lester SC (2005) The Breast. In Kumar V, Abbas A, Fausto N (eds) Robbins and Cotran Pathological Basis of Disease. Philadelphia: Elsevier Saunders, pp. 1059-1154.
2. Fattaneh AT, Devilee P (2003) World Health Organization Classification of Tumours. IARC Press, Lyon.
3. Mallon E, Osin P, Nasiri N et al. (2000) The basic pathology of human breast cancer. J Mammary Gland Biol Neoplasia 5: 139-163. (Pubitemid 32045693)
4. Ring BZ, Ross DT (2002) Microarrays and molecular markers for tumor classification. Genome Biol 3: 1-6.
5. Fulford LG, Easton DF, Reis-Filho JS et al. (2006) Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology 49: 22-34. (Pubitemid 43972917)
6. Ellis IO, Pinder SE, Bobrow L (2005) NHS breast screening programme. Pathology reporting of breast disease. NHS cancer screening programme and The Royal College of Pathologists.
7. Nielsen TO, Hsu FD, Jensen K et al. (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Canc Res 10: 5367-5374. (Pubitemid 39100473)
8. Hoadley KA, Perou CM (2005) Identification of drug targets for the treatment of basal like tumours. Breast Canc Res 7: 6.01.
9. Rakha EA, Puffi TC, Abd El-Rehim DM et al. (2006) Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol 208: 495-506. (Pubitemid 43329336)
10. Laakso M, Loman N, Borg A et al. (2005) Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors. Mod Pathol 18: 1321-1328. (Pubitemid 41348650)
11. Matos I, Dufloth R, Alvarenga M et al. (2005) p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch 447: 688-694. (Pubitemid 41571183)
12. Ribeiro-Silva A, Ramalho LNZ, Garcia SB et al. (2005) p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer. Histopathology 47: 458-466. (Pubitemid 41626723)
13. Siziopikou KP, Cobleigh M (2007) The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies. Breast 16: 104-107. (Pubitemid 46172864)
14. Livasy CA, Karaca G, Nanda R et al. (2006) Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol 19: 264-271. (Pubitemid 43117611)
15. Banerjee S, Reis-Filho JS, Ashley S et al. (2006) Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol 59: 729-735. (Pubitemid 44048783)
16. Hsi ED, Tubbs RR (2004) Guidelines for HER2 testing in the UK. J Clin Pathol 57: 241-242. (Pubitemid 38338832)
17. Reis-Filho JS, Milanezi F, Steele D et al. (2006) Metaplastic breast carcinomas are basal-like tumours. Histopathology 49: 10-21. (Pubitemid 43972916)
18. Laakso M, Tanner M, Nilsson J et al. (2006) Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer. Clin Canc Res 12: 4185-4191.
19. Jumppanen M, Gruvberger-Saal S, Kauraniemi P et al. (2007) Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers. Breast Canc Res 9: R16.
20. Rakha EA, El-Sayed ME, Green AR et al. (2007) Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression. Histopathology 50: 434-438. (Pubitemid 46328193)
21. Rodriguez-Pinilla SM, Sarrio O, Honrado E et al. (2006) Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas. J Clin Pathol 60: 1006-1012.
22. Bryan BB, Schnitt SJ, Collins LC (2006) Ductal carcinoma in situ with basallike phenotype: a possible precursor to invasive basal-like breast cancer. Mod Pathol 19: 617-621.
23. Kusinska R, Potemski P, Jesionek-Kupnicka D et al. (2005) Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma-relation with grade, stage, estrogen receptor and HER2. Pol J Pathol 56: 107-110. www.cancerscreening.nhs.uk/breastscreen/ breastcaner.html. (Accessed 1/4/07). (Pubitemid 41686620)